DEXCOM INC reported revenue of $1.31B for the period ended 2026-06-30, +13.1% year on year. Net income was $0.25B, a 19.0% net margin on a 63.4% gross margin. The largest revenue line is US at 71% of the total. Free cash flow for the period was $0.18B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $1.31B | +13.1% |
| Gross profit | $0.83B | — |
| Operating income | $0.32B | — |
| Net income | $0.25B | +38.5% |
| Gross margin | 63.4% | Net margin 19.0% |
| Revenue Q/Q | +9.8% | — |
| Segment | Revenue | Share |
|---|---|---|
| US | $0.93B | 71.3% |
| Non Us | $0.38B | 28.7% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $0.48B | 36.6% |
| R&D | $0.15B | 11.7% |
| SG&A | $0.36B | 27.4% |
| Tax & other | $0.07B | 5.3% |
| Item | Amount |
|---|---|
| Total assets | $6.46B |
| Total liabilities | $3.83B |
| Shareholders' equity | $2.62B |
| Equity / assets | 40.6% |
| Operating cash flow | $0.27B |
| Capital expenditure | $0.08B |
| Free cash flow | $0.18B |
| Cash conversion (OCF / net income) | 108% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
FANG ・ DLR ・ DG ・ DLTR ・ D ・ DPZ ・ DASH ・ DOV ・ DOW ・ DHI ・ DTE ・ DUK
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies